UCLA scientists engineer ready-to-use cancer-fighting T cells for solid tumors
On Sept. 8, 2026, researchers from the University of California, Los Angeles (UCLA) announce they have developed a…
On Sept. 8, 2026, researchers from the University of California, Los Angeles (UCLA) announce they have developed a…
On Sept. 4, 2026, the U.S. Food and Drug Administration (FDA) announced they have expanded treatment options for…
On Aug. 28, 2026, scientists from Gladstone Institutes, UC San Francisco, and Stanford University, in collaboration with Biohub,…
On Aug. 26, 2026, the U.S. Food and Drug Administration (FDA) approved Rasonque (daraxonrasib), a RAS inhibitor for…
On Aug. 10, 2026, scientists at St. Jude Children’s Research Hospital announce they have created a single-cell atlas…
On Aug. 10, 2026, Labcorp announced that the U.S. Food and Drug Administration (FDA) had approved Labcorp’s PGDx elio®…
On Aug. 5, 2026, an international team led by researchers at MIT’s Koch Institute, the Broad Institute, the…
On Jul. 31, 2026, Novartis announced the US Food and Drug Administration (FDA) approved Pluvicto® (lutetium Lu 177…
On Jul. 30, 2026, a study led by Cedars-Sinai Health Sciences University investigators found that women who test…
On Jul. 30, 2026, researchers at the University of Virginia’s (UVA) Department of Radiology and Medical Imaging have…
On Jul. 30, 2026, researchers and clinicians from the University of Liverpool and the Clatterbridge Cancer Centre (CCC)…
On Jul. 28, 2026, The U.S. Food and Drug Administration (FDA) announced it had approved SimpleScreen™ CRC, a…
On Jul. 24, 2026, a team led by LIAN Jiazhang at Zhejiang University’s College of Chemical and Biological…
On Jul. 20, 2026, Tempus AI, a technology company leading the adoption of AI to advance precision medicine…
On Jul. 14, 2026, the Food and Drug Administration approved gedatolisib (Revtorpyk, Celcuity) in combination with fulvestrant, with…
On July 9, 2026, researchers at the University of British Columbia announced they have identified a new form of hereditary…
On Jul. 7, 2026, the Association of American Universities (AAU) released new data showing that major research universities…
On Jul. 3, 2026, a research team led by Helmholtz Munich and Ludwig Maximilian University has developed TAPIR,…
On Jul. 1, 2026, a study led by a researcher based at King’s College London and McMaster University…
On Jul. 1, 2026, tech giant Anthropic announced it has extended its foray into the life sciences space…
On Jun. 29, 2026, AstraZeneca and Daiichi Sankyo’s announced that Enhertu (trastuzumab deruxtecan) had been approved in the…
On Jun. 29, 2026, China announced it has broken ground on what developers say is the country’s first…
On Jun. 25, 2026, researchers from the Nara Institute of Science and Technology report that every time a…
On Jun. 24, 2026, Antares Therapeutics announce it has entered a collaboration with Novartis that could be worth…
On Jun. 24, 2026, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) has approved Trodelvy®…
On Jun. 23. 2026, scientists at Cornell University announce discovering a delivery system that uses lipid nanoparticles to…
On Jun. 23, 2026 – researchers from the Pacific Northwest Research Institute in Seattle announced they have identified…
On Jun. 21, 2026, Chen Weiqiang, formerly a tenured professor of mechanical and biomedical engineering at New York…
On Jun. 19, 2026, University of Southern California (USC) scientists report in a paper published in Cell, a…
On Jun. 9, 2026, GSK announced that it has entered an agreement to acquire Nuvalent, a Boston-based clinical-stage…